Company: PMVP
Filing Date: 2025-04-25
Form Type: DEF 14A
Source: 0001140361-25-015610
Chunk: 50

Company: PMV Pharmaceuticals, Inc.
Filing Date: 2025-04-25
Form: DEF 14A
Chunk 50
---
 to the extent of any pecuniary interest therein. |

| (7) | Consists of (i) 88,395 shares of common stock held directly by Mr. Carulli and (ii) 109,403 shares of common stock issuable pursuant to options held directly by Mr. Carulli, exercisable within 60 days of April 8, 2025. |

| (8) | Consists of (i) 123,024 shares of common stock held directly by Dr. Jalota and (ii) 202,883 shares of common stock issuable pursuant to options held directly by Dr. Jalota, exercisable within 60 days of April 8, 2025. |

| (9) | Consists of 124,338 shares of common stock issuable pursuant to options held directly by Dr. Baum, exercisable within 60 days of April 8, 2025. |

| (10) | Consists of 111,167 shares of common stock issuable pursuant to options held directly by Ms. Flowers, exercisable within 60 days of April 8, 2025. |

| (11) | Consists of 92,583 shares of common stock issuable pursuant to options held directly by The Gallagher Revocable Trust dated May 10, 2011, for which Carol Gallagher, Pharm.D. serves as a trustee, exercisable within 60 days of April 8, 2025. |

| (12) | Consists of (i) 300,560 shares of common stock issuable pursuant to options held directly by Dr. Heyman, exercisable within 60 days of April 8, 2025; (ii) 20,098 shares of common stock issuable pursuant to options held by Paul L. Vogel as trustee of the Heyman Family 2020 Irrevocable Trust, of which Dr. Heyman’s immediate family are beneficiaries, exercisable within 60 days of April 8, 2025; (iii) 10,050 shares of common stock issuable pursuant to options held by Paul L. Vogel as trustee of the Julia E. Heyman 2016 Irrevocable Trust, of which Dr. Heyman’s daughter and descendants are beneficiaries, exercisable within 60 days of April 8, 2025; and (iv) 10,050 shares of common stock issuable pursuant to options held by Paul L. Vogel as trustee